Biotest AG
BIESF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,095 | $1,239 | $1,532 | $1,475 |
| - Cash | $108 | $108 | $117 | $104 |
| + Debt | $597 | $614 | $574 | $496 |
| Enterprise Value | $1,584 | $1,745 | $1,989 | $1,867 |
| Revenue | $726 | $685 | $516 | $516 |
| % Growth | 6.1% | 32.6% | 0.1% | – |
| Gross Profit | $224 | $280 | $125 | $81 |
| % Margin | 30.8% | 40.9% | 24.2% | 15.7% |
| EBITDA | $120 | $182 | $25 | -$18 |
| % Margin | 16.6% | 26.6% | 4.8% | -3.5% |
| Net Income | $26 | $127 | -$32 | -$63 |
| % Margin | 3.6% | 18.6% | -6.1% | -12.3% |
| EPS Diluted | 0.71 | 3.21 | -0.8 | -1.6 |
| % Growth | -77.9% | 501.2% | 50% | – |
| Operating Cash Flow | $61 | -$3 | -$41 | $34 |
| Capital Expenditures | -$29 | -$33 | -$29 | -$18 |
| Free Cash Flow | $32 | -$36 | -$70 | $16 |